TxCell: Getting Production In Order – Investing.com
|
TxCell: Getting Production In Order
Investing.com Txcell (PA:TXCL) has agreed an important manufacturing supply contract with Lentigen, a German-US producer of the critical lentivirus reagent essential for modifying T–cells. This is a core element for the development of CAR-modified regulatory T–cells … |
